2023
ZOLL Expands Temperature Management Portfolio to Include IQool™ System, High-Quality Surface Option
Monday, July 24, 2023 in Chelmsford, Mass.
ZOLL remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional Use
Wednesday, May 24, 2023 in Chelmsford, Mass.
Results from Benefit of Microcor in Ambulatory Decompensated Heart Failure (BMAD) Trial Presented as ACC.23/WCC Late-Breaking Clinical Trial
Monday, March 6, 2023 in Chelmsford, Mass.
First Patient Enrolled in REAL SSO2 Study to Evaluate Clinical Utility and Economic Value of ZOLL TherOx SSO2 Therapy
Tuesday, January 17, 2023 in Chelmsford, Mass.
2022
ZOLL Awarded Diagnostic and Interventional Cardiology Catheter Agreement with Premier, Inc. for TherOx SuperSaturated Oxygen Therapy
Monday, October 31, 2022 in Chelmsford, Mass.
ZOLL Selected to Exhibit TherOx SSO2 Therapy at Vizient Innovative Technology Exchange
Monday, October 3, 2022 in Chelmsford, Mass.
First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients
Wednesday, September 7, 2022 in Chelmsford, Mass.
Centers for Medicare & Medicaid Services (CMS) Issue New ICD-10-PCS Code for ZOLL Medical's TherOx SSO2 Therapy
Thursday, July 14, 2022 in Chelmsford, Mass.
ZOLL Launches Next Generation MCT Solution, Shown to Improve Patient Management Decisions in Largest Ever MCT Trial
Monday, March 21, 2022 in Chelmsford, Mass.
ZOLL Foundation Announces Grant Application Submission Deadline of March 31, 2022
Thursday, January 13, 2022 in Chelmsford, Mass.
2021
ZOLL Announces Closing of Acquisition of Itamar Medical
Thursday, December 16, 2021 in Chelmsford, Mass.
ZOLL TherOx SuperSaturated Oxygen Therapy to be Highlighted at TCT Scientific Symposium
Thursday, November 4, 2021 in Chelmsford, Mass.
ZOLL's TherOx SuperSaturated Oxygen Therapy to be Highlighted at SCAI Shock Virtual Conference
Tuesday, October 5, 2021 in Chelmsford, Mass.
ZOLL Medical Corporation Signs Definitive Agreement to Acquire Itamar Medical
Monday, September 13, 2021 in Chelmsford, Mass.
ZOLL and Wallaby Medical Announce Agreement to Distribute Temperature Management Products in China
Monday, August 23, 2021 in Chelmsford, Mass.
American Medical Association Issues New Category III CPT Code for ZOLL Medical’s TherOx SSO₂ Therapy
Monday, August 9, 2021 in Chelmsford, Mass.
ZOLL Announces Approval of Next-Generation remedē System for the Treatment of Central Sleep Apnea (Transvenous Phrenic Nerve Stimulation)
Thursday, August 5, 2021 in Chelmsford, Mass.
ZOLL Medical Receives FDA Clearance for TBI Dashboard on Its Propaq M Monitor and Propaq MD Monitor/Defibrillator
Wednesday, July 21, 2021 in Chelmsford, Mass.
ZOLL and Global Healthcare SG Sign Exclusive Agreement for Distribution of Portable Targeted Temperature Management System in Asia Pacific
Tuesday, June 1, 2021 in Chelmsford, Mass.
ZOLL Accelerates EMS Participation in New York State Data Exchange Incentive Program
Tuesday, May 25, 2021 in Chelmsford, Mass.
ZOLL Announces Five-Year Study Confirming Safety, Efficacy and Beneficial Effects of Long-Term Transvenous Phrenic Nerve Stimulation (the Remedē System)
Monday, May 17, 2021 in Chelmsford, Mass.
ZOLL Medical Receives FDA IDE Approval for Initiation of ISO SHOCK (Incorporating Supersaturated Oxygen in Shock) Feasibility Study
Thursday, May 13, 2021 in Chelmsford, Mass.
ZOLL Medical Corporation Acquires Respicardia, Inc
Monday, April 12, 2021 in Chelmsford, Mass.
Asahi Kasei Company ZOLL Medical Corporation Donates $10M to The ZOLL Foundation to Support the Next Generation of Innovative Researchers in Resuscitation and Acute Critical Care
Tuesday, March 9, 2021 in Chelmsford, Mass.
ZOLL Foundation Grants to Nearly 70 Recipients in Resuscitation and Critical Care Research Surpass $2.5 Million
Wednesday, January 27, 2021 in Chelmsford, Mass.
ZOLL Medical's Advanced Defibrillators Win Five-star World Of Safety And Health Asia Award 2020
Wednesday, January 6, 2021 in Chelmsford, Mass.